about
Polymer-drug conjugates: origins, progress to date and future directionsExperiments and synthesis of bone-targeting epirubicin with the water-soluble macromolecular drug delivery systems of oxidized-dextran.Selectivity in bone targeting with multivalent dendritic polyanion dye conjugates.Macromolecular therapeuticsModular 'click-in-emulsion' bone-targeted nanogels.Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo.POLYMERIC BIOMATERIALS AND NANOMEDICINES.Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats.A Simple and Efficient Synthesis of an Acid-labile Polyphosphoramidate by Organobase-catalyzed Ring-Opening Polymerization and Transformation to Polyphosphoester Ionomers by Acid TreatmentDesign and Biological Evaluation of Delivery Systems Containing BisphosphonatesPotential of targeted drug delivery system for the treatment of bone metastasis.Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering.DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.Synthesis and evaluation of alendronate-modified gelatin biopolymer as a novel osteotropic nanocarrier for gene therapy.Local and targeted drug delivery for bone regeneration.Anti-Resorptive Functions of Poly(ethylene sodium phosphate) on Human Osteoclasts.Advances in Controlled Drug Delivery for Treatment of OsteoporosisOsteotropic polypeptide nanoparticles with dual hydroxyapatite binding properties and controlled cisplatin delivery.Bone-targeted acid-sensitive doxorubicin conjugate micelles as potential osteosarcoma therapeutics.Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer.Biodistribution of Fracture-Targeted GSK3β Inhibitor-Loaded Micelles for Improved Fracture Healing.Bone-seeking agents for the treatment of bone disorders.Engineering nanocages with polyglutamate domains for coupling to hydroxyapatite biomaterials and allograft bone.In vivo imaging of bone using a deep-red fluorescent molecular probe bearing multiple iminodiacetate groups.Gelatin Nanoparticles with Enhanced Affinity for Calcium Phosphate.Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.Bone-targeting poly(ethylene sodium phosphate).Engineered Multifunctional Nanomedicine for Simultaneous Stereotactic Chemotherapy and Inhibited Osteolysis in an Orthotopic Model of Bone Metastasis.Development of Controlled Drug Delivery Systems for Bone Fracture-Targeted Therapeutic Delivery: A Review.Bidentate iminodiacetate modified dendrimer for bone imaging.Bisphosphonate conjugation for bone specific drug targeting.Nanoprobes for Multimodal Visualization of Bone Mineral Phase in Magnetic Resonance and Near-Infrared Optical Imaging.
P2860
Q27002505-4F25FEAB-97E0-441C-8FB4-705ACF52115EQ30729687-D03ADACE-B2F8-4245-B435-673091EE08CDQ31136234-E837C79A-85A8-4BA9-94AE-ABF65C29E35FQ34079574-162A15B1-3162-485D-9732-E0DE4F30B682Q34320432-2A074307-5A4B-4529-A7DB-08AD3D42C452Q35749975-711B4903-3DB4-41AA-B672-432BA90F1E6DQ36376467-639B2934-41EB-4008-BB4F-D1DEF9FC053AQ36940281-AACEBAF5-3E3A-43ED-BD4A-4FB6CCA77FE4Q37127841-64FF61A3-6D73-46D1-B264-12A781C023D4Q37731222-B2014E86-C639-4685-A4D8-398893498748Q38212708-75B3DEC5-CDE1-41DA-A752-E1B28AA57FD3Q38367669-36B55C83-28F9-451C-8FCD-7A0F7FFE14DAQ38740618-7131ECB2-C6DE-405D-86B6-354142B50ACFQ38751743-44BAAA80-5A3A-4DC6-9855-801F05A88C47Q38804309-09A5CFC1-19BE-48EC-8E36-72CD5CB05559Q38848170-4B80D95E-DA7C-4DEE-9C49-35AA86A39F20Q38922086-942C1392-9B4A-4B04-9BA3-D363F94A3078Q38928697-536EBFE7-26FF-4083-9B65-3AB09570006BQ38949970-4B461290-A34C-401F-B83D-427BA797A8B3Q39138688-E4693C15-50E2-4271-BB82-38381FF44F60Q39254173-CF5D78C7-6CB2-4B12-8599-172BEF8756EEQ39356298-4EBA5E9C-80F0-4CDC-B8A0-9D745F5360C4Q41875872-22B6D1FF-0FB3-4032-9AAF-B883F47B1BA4Q42000940-FE1E202A-9B81-4AB7-823D-B03E91DFFEB2Q46278996-9AD485D4-A8D7-400B-8554-F13EEDCEB5A5Q47142933-D1425307-D1A9-47BD-8AFA-DCA24EB91656Q47304447-531DDCBD-09A7-4B3E-9080-838427B52B27Q48333845-726EF891-882A-44BB-B3FB-7A241FAFEC3DQ51748839-07CEFE7B-3114-4BB1-B603-92B58F123A15Q55065973-84BFA5F6-5ECE-424B-B9AA-8EFE2986E8B8Q55515922-4D5D8C61-83E3-40B3-AAE9-211C9BDE8C04Q55664595-C41CB626-2679-4922-9C1D-37F3B709090E
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Targeting polymer therapeutics to bone.
@ast
Targeting polymer therapeutics to bone.
@en
type
label
Targeting polymer therapeutics to bone.
@ast
Targeting polymer therapeutics to bone.
@en
prefLabel
Targeting polymer therapeutics to bone.
@ast
Targeting polymer therapeutics to bone.
@en
P2860
P1476
Targeting polymer therapeutics to bone.
@en
P2093
Jindřich Kopeček
Stewart A Low
P2860
P304
P356
10.1016/J.ADDR.2012.01.012
P407
P577
2012-01-28T00:00:00Z